Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Johnson & Johnson

Insiders have been trading these 5 stocks: (($INTC)), (($NFLX)), (($PFE)), (($KO)) and (($JNJ)). Here is a breakdown of their recent trades and the...

Intel, Netflix, Pfizer, Coca-Cola, J&J Insider Shock

Insiders have been trading these 5 stocks: (($KO)), (($CRWD)), (($JNJ)), (($UNH)) and (($CVX)). Here is a breakdown of their recent trades and thei...

Coca-Cola, CrowdStrike, J&J, UnitedHealth, Chevron Insider Shake-Up

Many investors focus on building a large retirement portfolio. However, the bigger challenge is turning those savings into steady income. Vanguard ...

3 Best Vanguard ETFs to Build Passive Income in Retirement

For investors seeking dependable dividend income, International Business Machines ($IBM), Johnson & Johnson ($JNJ), and Coca-Cola ($KO) stand out. ...

3 ‘Strong Buy’ Dividend Aristocrat Stocks for Dependable Income, 8/5/26

Johnson & Johnson ( ($JNJ) ) has provided an announcement. On August 4, 2026, Johnson & Johnson announced that Jennifer Taubert will retire as Exec...

Johnson & Johnson announces leadership change in Innovative Medicine

An announcement from Johnson & Johnson ( ($JNJ) ) is now available. On July 29, 2026, Johnson & Johnson completed its $1 billion cash acquisition o...

Johnson & Johnson Updates Guidance After Firefly, Sail Deals

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Johnson & Johnson (JNJ), Medios AG (MEDOF) and Neuro...

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Medios AG (OtherMEDOF) and NeuroPace (NPCE)

In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Johnson & Johnson, with a price target of $300.00. Toung...

Johnson & Johnson (JNJ) Gets a Buy from Argus Research

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Boston Scientific (BSX), Intuitive Surgical (ISRG) a...

Analysts’ Top Healthcare Picks: Boston Scientific (BSX), Intuitive Surgical (ISRG)

Johnson & Johnson ($JNJ) shares rose 1.52% in after-hours trading on Monday after the company announced a $5.5 billion settlement to resolve tens o...

J&J Strikes $5.5B Talc Settlement after Years of Lawsuits; JNJ Stock Rises

Insiders have been trading these 5 stocks: (($TSM)), (($JNJ)), (($MSTR)), (($SNAP)) and (($MMM)). Here is a breakdown of their recent trades and th...

Insiders Shake Up TSMC, Johnson & Johnson, Strategy, Snap, 3M

Market volatility amid the ongoing earnings season and Middle East tensions continues to impact investor sentiment. In an uncertain backdrop, inves...

Best ETFs to Invest In, According to AI Analyst, 7/23/2026

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Johnson & Johnson (JNJ), Helus Pharma (HELP) and Nek...

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Helus Pharma (HELP) and Nektar Therapeutics (NKTR)

Shares in medical group Johnson & Johnson ($JNJ) were healthier today after it received the green light to begin the “next era” of robotic surgery....

Johnson & Johnson Continues Recovery After Green Light Given to ‘Next Era’ Robotic Surgeon

The approval opens a new market for the healthcare company. 


Johnson & Johnson Stock (JNJ) Rises as Robotic Surgery Device Is Approved

Investors looking for steady cash payments can bank on NextEra ($NEE), Coca-Cola ($KO), and Johnson & Johnson ($JNJ). Top analysts covering these s...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	JNJ	$270.27	+3.01%	3.55M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	JNJ	$270.27	+3.0%	3.55M
3
4
5
6

JNJ

Get Johnson & Johnson Data in Excel

Get Johnson & Johnson Data in Excel